Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-05

Clinical Trial Update: Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluates adding Traditional Chinese Medicine to standard triple therapy for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Standard triple therapy for Helicobacter pylori
  • Traditional Chinese Medicine adjunct

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Helicobacter Pylori Infection | Phase 1, Phase 2 | Status: COMPLETED